https://www.docwirenews.com/docwire-pick/home-page-picks/does-angiotensin-ii-inhibition-improve-covid-19-outcomes/
0
0
4/14/23 at 1:53pm
Organization
Docwirenews.com
32 words
0
Comments
In a recent randomized trial, ACE2 inhibitors did not improve, and even likely worsened, outcomes of critically-ill patients with COVID-19.
You are the first to view
Create an account
or login to join the discussion